Select News Languages

English

Arabic

Telugu

Hindi

France

Log in

Have no account yet? Sign up

Create an account

I read and accept the Terms and conditions.

Already have an account? Log in

Reset password

Remember your password? Log in

Terms and conditions

Terms and Conditions

These terms and conditions apply to the News National app (hereby referred to as "Application") for mobile devices that was created by (hereby referred to as "Service Provider") as an Ad Supported service.

Upon downloading or utilizing the Application, you are automatically agreeing to the following terms. It is strongly advised that you thoroughly read and understand these terms prior to using the Application. Unauthorized copying or modification of the Application, any part of the Application, or our trademarks is strictly prohibited. Any attempts to extract the source code, translate the Application into other languages, or create derivative versions are not permitted. All intellectual property rights remain the property of the Service Provider.

The Service Provider is dedicated to ensuring the Application is as beneficial and efficient as possible. They reserve the right to modify the Application or charge for services at any time and for any reason. Any such charges will be clearly communicated.

The Application stores and processes personal data provided by you. You are responsible for maintaining the security of your device and access to the Application. Jailbreaking or rooting your device is strongly discouraged as it may compromise security and application performance.

Third-Party Services

The Application uses third-party services that have their own Terms and Conditions. Refer to the following links:

Google Play Services
AdMob
Google Analytics for Firebase
Firebase Crashlytics

Limitations and Responsibilities

Some Application functions require an internet connection (Wi-Fi or mobile data). The Service Provider is not responsible if the Application does not function fully due to lack of access or depleted data. If using the Application outside a Wi-Fi area, you accept responsibility for any charges incurred, including roaming fees. If you are not the bill payer, it is assumed you have obtained permission.

It is your responsibility to keep your device charged. The Service Provider is not responsible if the device is unavailable due to a drained battery.

While the Service Provider strives to keep the Application updated and accurate, they rely on third-party data and do not accept liability for losses caused by reliance on Application functionality.

Updates and Termination

The Application may be updated to remain compatible with the operating system. You agree to install updates as offered. The Service Provider may discontinue the Application at any time without notice. Upon termination:

Rights and licenses granted to you will end.
You must stop using the Application and delete it from your device.

Changes to These Terms and Conditions

The Service Provider may update these Terms and Conditions periodically. Please review this page regularly. Changes will be posted on this page.

Effective Date: 2025-07-23

Contact Us

If you have questions or suggestions about the Terms and Conditions, contact the Service Provider at:
📧 info@news-national.com

Do you agree to our terms? Sign up

India-US Trade Deal In Focus: What Recent Meetings Reveal Amid Rising Trade Tariff Pressures

ABP LIve

3 hours ago

1

0 👍 ❤️ 😂 😮 😢 😡

Amid a growing tariff row, India and the United States have reaffirmed their commitment to fast-tracking discussions on a mutually beneficial Bilateral Trade Agreement (BTA). An Indian delegation, led by Commerce and Industries Minister Piyush Goyal, visited the US between September 22 and 24 to meet senior government officials, businesses, and investors.

“Both sides exchanged views on possible contours of the deal and it was decided to continue the engagements with a view to achieve early conclusion of a mutually beneficial Trade Agreement,” the government said in a statement.

Key Meetings with US Officials and Businesses

During the visit, Goyal held meetings with Ambassador Jamieson Greer, United States Trade Representative, and Sergio Gor, US Ambassador-designate to India, where bilateral trade issues were discussed.

The Indian delegation also engaged with major US-based businesses and investors to strengthen economic ties. According to the government, the discussions received a “positive response,” with business leaders expressing confidence in the India growth story and showing willingness to expand their activities in the country.

Tariffs and Visa Fee Add Strain to Trade Relations

The renewed push for a trade pact comes against the backdrop of recent tariff hikes by the US and a steep new visa fee.

In July, President Trump imposed 25 per cent tariffs on Indian goods despite earlier expectations of an interim trade agreement.

A few days later, an additional 25 per cent tariff was announced, raising the total tariff burden to 50 per cent, citing India’s continued imports of Russian oil. These tariffs came into effect on August 27.

Last week, Trump introduced a $100,000 fee on new H1-B visa petitions, a move set to hit Indian professionals the hardest, who account for over 72 per cent of H1-B workers.

From October 1, 2025, the US will also impose a 100 per cent tariff on branded and patented pharmaceutical products, which could significantly impact India, home to the largest number of US FDA-approved plants outside America, according to the India Brand Equity Foundation.

Agriculture and Dairy a Sticking Point

While both countries are negotiating for a balanced outcome, India has reservations over US demands to open its agriculture and dairy sectors. These sectors are considered critical and sensitive, providing livelihood to millions of Indians.

India and the US began talks for the Bilateral Trade Agreement (BTA) in March 2025, with an aim to complete the first stage of negotiations by October–November 2025.

Pharma Exports at Risk from New Tariffs

India’s pharmaceutical exports are among the sectors most exposed to US tariff actions. In FY25 (April–December), India exported Rs 1.87 lakh crore ($21.7 billion) worth of pharmaceutical products, with the US, UK, South Africa, the Netherlands, and France as key destinations.

Globally, India’s pharma exports stood at over $30 billion in 2024-25, with formulations and biologics making up nearly 79 per cent of the total.

Click here to Read more